Ischaemic stroke in incident dialysis patients

Nephrology Dialysis Transplantation

Volumn 25, Issue 10, 2010, Pages 3343-3348

  Sánchez Perales, Carmen ^a   Vázquez, Eduardo ^b   García Cortés, M José ^a   Borrego, Josefa ^a   Polaina, Manuel ^a   Gutiérrez, C Patricia ^a   Lozano, Cristóbal ^b   Liébana, Antonio ^a  

^a Nephrology   (Spain)

^b Cardiology Service   (Spain)

Author keywords

atrial fibrillation; dialysis; ischaemic stroke; mineral metabolism

Indexed keywords

ALBUMIN; CALCIUM; COUMARIN; CREATININE; LIPID; PARATHYROID HORMONE; PHOSPHORUS; UREA;

ADULT; ANTICOAGULANT THERAPY; ARTICLE; BRAIN ISCHEMIA; DEATH; DIABETES MELLITUS; FEMALE; FOLLOW UP; GENDER; HEART ATRIUM FIBRILLATION; HEMATOCRIT; HEMODIALYSIS PATIENT; HUMAN; HYPERTENSION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PERIPHERAL VASCULAR DISEASE; PREVALENCE; PRIORITY JOURNAL; PROPHYLAXIS; SMOKING HABIT;

ADULT; AGED; ATRIAL FIBRILLATION; BRAIN ISCHEMIA; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PREVALENCE; RENAL DIALYSIS; STROKE;

EID: 77957237745     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq220     Document Type: Article

References (35)

1. Iseki K, Kinjo K, Kimura Y et al. Evidence for high risk of cerebral hemorrhage in chronic dialysis patients. Kidney Int 1993; 44: 1086-1090
2. Seliger SL, Gillen DL, Longstreth WT et al. Elevated risk of stroke among patients with end-stage renal disease. Kidney Int 2003; 64: 603-609
3. Sozio SM, Armstrong PA, Coresh J et al. Cerebrovascular disease incidence, characteristics, and outcomes in patients initiating dialysis: the choices for healthy outcomes in caring for ESRD (CHOICE) study. Am J Kidney Dis 2009; 54: 468-477
4. Seliger SL. Stroke in ESRD: the other cardiovascular disease. Am J Kidney Dis 2009; 54: 403-405
5. Korantzopoulos P, Kokkoris S, Liu T et al. Atrial fibrillation in end-stage renal disease. Pacing Clin Electrophysiol 2007; 30: 1391-1397
6. Longenecker JC, Coresh J, Powe NR et al. Traditional cardiovascular disease risk factors in dialysis patients compared with the general population: the CHOICE Study. J Am Soc Nephrol 2002; 13: 1918-1927
7. Goodkin DA, Bragg-Gresham JL, Koenig KG et al. Association of co-morbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States: the Dialysis Outcomes and Practice Patterns Study (DOPPS). J Am Soc Nephrol 2003; 14: 3270-3277
8. Delmez JA, Yan G, Bailey J et al. Hemodialysis (HEMO) Study Group. Cerebrovascular disease in maintenance hemodialysis patients: results of the HEMO Study. Am J Kidney Dis 2006; 47: 131-138
9. Kawamura M, Fijimoto S, Hisanaga S et al. Incidence, outcome, and risk factors of cerebrovascular events in patients undergoing maintenance hemodialysis. Am. J Kidney Dis 1998; 31: 991-996
10. Goodkin DA, Mapes DL, Held PJ. The dialysis outcomes and practice patterns study (DOPPS): how can we improve the care of hemo-dialysis patients?. Semin Dial 2001; 14: 157-159
11. Toyoda K, Fujii K, Fujimi S et al. Stroke in patients on maintenance hemodialysis: a 22-year single-center study. Am J Kidney Dis 2005; 45: 1058-1066
12. Seliger SL, Gillen DL, Tirschwell D et al. Risk factors for incident stroke among patients with end-stage renal disease. J Am Soc Nephrol 2003; 14: 2623-2631
13. Wanner C, Krane V, Marz W et alfor the German Diabetes and Dialysis Study Group. Atorvastatin in patients with type 2 diabetes mel-litus undergoing hemodialysis. N Engl J Med 2005; 353: 238-248
14. Fellström BC, Jardine AG, Schmieder RE et alAURORA Study Group. Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. N Engl J Med 2009; 360: 1395-1407
15. Caicoya M, Rodríguez T, Lasheras C et al. Stroke incidence in As-turias (1990-1991). Rev Neurol 1996; 24: 806-811
16. Covic A, Kothawala P, Bernal M et al. Systematic review of the evidence underlying the association between mineral metabolism disturbances and risk of all-cause mortality, cardiovascular mortality and cardiovascular events in chronic kidney disease. Nephrol Dial Transplant 2009; 24: 1506-1523
17. Slinin Y, Foley RN, Collins AJ. Calcium, phosphorus, parathyroid hormone, and cardiovascular disease in hemodialysis patients: the USRDS waves 1, 3, and 4 study. J Am Soc Nephrol 2005; 16: 1788-1793
18. Marti-Vilalta JL, Arboix A. The Barcelona Stroke Registry. Eur Neu-rol 1999; 41: 135-142
19. Naganuma T, Uchida J, Tsuchida K et al. Silent cerebral infarction predicts vascular events in hemodialysis patients. Kidney Int 2005; 67: 2434-2439
20. Rothwell PM, Coull AJ, Silver LE et al. Oxford Vascular Study: population-based study of event-rate, incidence, case fatality, and mortality for all acute vascular events in all arterial territories (Oxford Vascular Study). Lancet 2005; 366: 1773-1783
21. Go AS, Fang MC, Udaltsova N et al. ATRIA Study Investigators: impact of proteinuria and glomerular filtration rate on risk of throm-boembolism in atrial fibrillation: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study. Circulation 2009; 119: 1363-1369
22. Vázquez E, Sánchez-Perales C, Borrego F et al. Influence of atrial fibrillation on the morbido-mortality of patients on hemodialysis. Am Heart J 2000; 140: 886-890
23. Vázquez-Ruiz de Castroviejo E, Sánchez-Perales C et al. Incidence of atrial fibrillation in hemodialysis patients. A prospective long-term follow-up study. Rev Esp Cardiol 2006; 59: 779-784
24. Vázquez E, Sánchez-Perales C, García-García F et al. Atrial fibrillation in incident dialysis patients. Kidney Int 2009; 76: 324-333
25. Vázquez E, Sánchez-Perales C, Lozano C et al. Comparison of prognostic value of atrial fibrillation versus sinus rhythm in patients on long-term hemodialysis. Am J Cardiol 2003; 92: 868-871
26. Wiesholzer M, Harm F, Tomasec G et al. Incidence of stroke among chronic hemodialysis patients with non-rheumatic atrial fibrillation. Am J Nephrol 2001; 21: 35-39
27. Genovesi S, Vincenti A, Rossi E et al. Atrial fibrillation and morbidity and mortality in a cohort of long-term hemodialysis patients. Am J Kidney Dis 2008; 51: 255-262
28. Vázquez E, Sánchez Perales C, García Cortés MJ et al. Ought dialysis patients with atrial fibrillation be treated with oral anticoagulants? Int J Cardiol 2003; 87: 135-139
29. Sánchez Perales MC, Vázquez E, García Cortés MJ et al. Platelet antiaggregation and hemorrhagic risk in hemodialysis. Nefrología 2002; 22: 456-462
30. Chan KE, Lazarus JM, Thadhani R et al. Warfarin use associates with increased risk for stroke in hemodialysis patients with atrial fibrillation. J Am Soc Nephrol 2009; 20: 2223-2233
31. Chan KE, Lazarus JM, Thadhani R et al. Anticoagulant and anti-platelet usage associates with mortality among hemodialysis patients. J Am Soc Nephrol 2009; 20: 872-881
32. Hörl WH. Coumarin use in dialysis patients with atrial fibrillation: yes, after individual risk stratification. Nephrol Dial Transplant 2009; 24: 3285-3287
33. Quinn RR, Naimark DM, Oliver MJ et al. Should hemodialysis patients with atrial fibrillation undergo systemic anticoagulation? A cost-utility analysis. Am J Kidney Dis 2007; 50: 421-432
34. Gage BF, Waterman AD, Shannon Wet al. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA 2001; 285: 2864-2870
35. Hankey GJ, Jamrozik K, Broadhurst RJ et al. Five-year survival after first-ever stroke and related prognostic factors in the Perth Community Stroke Study. Stroke 2000; 31: 2080-2086